Incidence of gestational trophoblastic disease in South Korea: a longitudinal, population-based study

PeerJ
Jin-Sung YukIn Ae Cho

Abstract

We investigated the rate and longitudinal trends of gestational trophoblastic disease (GTD) incidence in the Republic of Korea between 2009 and 2015 using population-based data. Data of patients diagnosed with GTD from 2009 to 2015 were obtained from the Health Insurance Review and Assessment Service/National Inpatient Sample (HIRA-NIS) in the Republic of Korea. The HIRA annually provides the HIRA-NIS, a collection of clinical data from over one million people. For each year, the HIRA-NIS extracted records of 13% of patients admitted at any one time during the year and 1% of all remaining patients using the weighted sample method. Medical records of 370,117 women with at least one pregnancy (GTD, ectopic pregnancy, abortion, or delivery) were extracted from a total of 4,476,495 records. Of these, 372 episodes of GTD were identified in women with a mean age of 35.4 ± 0.7 years. The incidence rate of GTD was 130 ± 10 cases per 100,000 pregnancies, which was classified as hydatidiform mole (HM), invasive mole, or malignant neoplasm of the placenta with incidence rates of 110 ± 10, 20 ± 0, or 10 ± 0 cases per 100,000 pregnancies, respectively. Incidence of GTD was lowest among women in their late 20 s and early 30 s. Occurrences of...Continue Reading

References

Dec 1, 1987·British Journal of Obstetrics and Gynaecology·M B Bracken
Jun 1, 1986·American Journal of Epidemiology·L A BrintonR R Connelly
Jun 1, 1986·British Journal of Obstetrics and Gynaecology·F ParazziniS Pampallona
Apr 1, 1986·American Journal of Obstetrics and Gynecology·H K AtrashD A Grimes
Jan 1, 1984·Advances in Experimental Medicine and Biology·M F AzizR S Samil
Feb 15, 2002·BJOG : an International Journal of Obstetrics and Gynaecology·N J SebireE Newlands
Feb 20, 2003·American Journal of Obstetrics and Gynecology·Harriet O SmithCharles R Key
Apr 1, 1963·American Journal of Obstetrics and Gynecology·P Y WEI, P C OUYANG
Nov 7, 2003·The Lancet Oncology·Andrea AltieriCarlo La Vecchia
Nov 15, 2003·Best Practice & Research. Clinical Obstetrics & Gynaecology·Stephen James Steigrad
Jul 11, 2006·Gynecologic and Obstetric Investigation·Hideo MatsuiSouei Sekiya
Aug 3, 2010·Lancet·Michael J SecklRoss S Berkowitz
Jan 21, 2011·Gynecologic Oncology·Charlotte LybolLeon F A G Massuger
Mar 15, 2011·Acta Oncologica·Sahar SalehiMats Lambe
Apr 1, 1998·International Journal of Gynaecology and Obstetrics : the Official Organ of the International Federation of Gynaecology and Obstetrics·S J KimJ M Lee
Dec 1, 2018·Archives of Pathology & Laboratory Medicine·Brigitte M Ronnett

❮ Previous
Next ❯

Citations

Jun 9, 2020·Journal of Family Medicine and Primary Care·Seyedeh Reyhaneh Yousefi Sharami, Elham Saffarieh
Feb 8, 2021·European Journal of Obstetrics, Gynecology, and Reproductive Biology·Vito Andrea CapozziRoberto Berretta

❮ Previous
Next ❯

Methods Mentioned

BETA
biopsies
hysterectomy
biopsy
Cesarean section
light microscopy
genotyping

Software Mentioned

R Core
R

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.